Company Filing History:
Years Active: 2015
Title: Ana I Kuehne: Innovator in Ebola Research
Introduction
Ana I Kuehne is a prominent inventor based in Frederick, MD (US). She has made significant contributions to the field of virology, particularly in the development of monoclonal antibodies for the detection and treatment of Ebola Sudan Boniface virus infections. Her work is crucial in advancing therapeutic options for this deadly virus.
Latest Patents
Ana I Kuehne holds a patent for "Monoclonal antibodies against glycoprotein of Ebola Sudan Boniface virus." This patent discloses the monoclonal antibodies, the epitopes recognized by these antibodies, and the sequences of the variable regions of some of these antibodies. The patent also includes mixtures of antibodies and methods for using them in the detection, prevention, and therapeutic treatment of Ebola Sudan Boniface virus infections, both in vitro and in vivo. She has 1 patent to her name.
Career Highlights
Ana I Kuehne is associated with the US Government as represented by the Secretary of the Army. Her work has been instrumental in addressing public health challenges posed by viral infections. She has dedicated her career to research that enhances our understanding and response to infectious diseases.
Collaborations
Ana has collaborated with notable colleagues, including John M Dye and Shawn B Guest. These partnerships have furthered her research efforts and contributed to the development of innovative solutions in the field of virology.
Conclusion
Ana I Kuehne is a key figure in the fight against Ebola, with her innovative research paving the way for new therapeutic approaches. Her contributions to science and public health are invaluable and continue to inspire future advancements in the field.